qRT-PCR analysis of BMMCs from patients with AML presenting with or without EMI (EMI = 24, non-EMI = 16) and healthy controls (n = 15) revealed that PLXNB2 mRNA was highly expressed in patients with AML (Fig. 1c). The gene discussed is PLXNB2; the disease is acute myeloid leukemia.